Johnson & Johnson
JNJ
$154.42
-$0.98-0.63%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
Weiss Ratings | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Weak | |||
Risk Grade | D+ | |||
Reward Grade | B | |||
Rating Factors | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Good | |||
Growth Index | Excellent | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.35 | |||
Price History | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -0.16% | |||
30-Day Total Return | 6.11% | |||
60-Day Total Return | -4.39% | |||
90-Day Total Return | -9.65% | |||
Year to Date Total Return | -13.75% | |||
1-Year Total Return | -12.50% | |||
2-Year Total Return | -7.32% | |||
3-Year Total Return | 0.93% | |||
5-Year Total Return | 7.22% | |||
52-Week High % Change | -14.70% | |||
52-Week Low % Change | 6.53% | |||
Price | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $181.04 | |||
52-Week Low Price | $144.95 | |||
52-Week Low Price (Date) | Oct 27, 2023 | |||
52-Week High Price (Date) | Dec 14, 2022 | |||
Valuation | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | $371.73B | |||
Enterprise Value | 378.14B | |||
Price/Earnings (TTM) | 11.48 | |||
Earnings Per Share (TTM) | 13.46 | |||
Earnings Per Share Growth | 87.45% | |||
Price/Earnings To Growth | 0.13 | |||
Price/Sales (TTM) | 4.50 | |||
Price/Book (Q) | 5.22 | |||
Enterprise Value/Revenue (TTM) | 4.32 | |||
Price | $154.42 | |||
Enterprise Value/EBITDA (TTM) | 11.72 | |||
Enterprise Value/EBIT | 15.21 | |||
Market Cap Category | Mega Cap | |||
Dividends and Shares | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 2.550B | |||
Dividend Yield | 3.04% | |||
Div. Per Share (Most Recent) | $1.19 | |||
Dividend Per Share (TTM) | $4.70 | |||
Payout Ratio (TTM) | 25.96% | |||
Dividend Per Share (Most Recent) | $1.19 | |||
Company Info | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 732 524 0400 | |||
Address | One Johnson & Johnson Plaza New Brunswick, NJ 08933 | |||
Website | www.jnj.com | |||
Country | United States | |||
Year Founded | 1886 | |||
Profitability | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 28.42% | |||
Profit Margin | 39.58% | |||
Management Effectiveness | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 9.11% | |||
Return on Equity | 17.44% | |||
Income Statement | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | $87.47B | |||
Total Revenue (TTM) | $87.47B | |||
Revenue Per Share | $34.31 | |||
Gross Profit (TTM) | $60.23B | |||
EBITDA (TTM) | $32.28B | |||
EBIT (TTM) | $24.86B | |||
Net Income (TTM) | $34.62B | |||
Net Income Avl. to Common (TTM) | $34.62B | |||
Total Revenue Growth (Q YOY) | 6.78% | |||
Earnings Growth (Q YOY) | -0.02% | |||
EPS Diluted (TTM) | $13.46 | |||
EPS Diluted Growth (Q YOY) | 509.23% | |||
Balance Sheet | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | $23.51B | |||
Cash Per Share (Q) | $9.22 | |||
Total Current Assets (Q) | $53.70B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | $71.23B | |||
Current Ratio (Q) | 1.210 | |||
Book Value Per Share (Q) | $29.59 | |||
Total Assets (Q) | $166.06B | |||
Total Current Liabilities (Q) | $44.37B | |||
Total Debt (Q) | $29.92B | |||
Total Liabilities (Q) | $94.83B | |||
Total Common Equity (Q) | $71.23B | |||
Cash Flow | JNJ - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -$4.86B | |||
Cash from Financing (TTM) | $1.85B | |||
Net Change in Cash (TTM) | $9.83B | |||
Levered Free Cash Flow (TTM) | $14.80B | |||
Cash from Operations (TTM) | $12.79B | |||